Compare AANJANEYA LIFECARE with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS JUBILANT LIFE SCIENCES DR. DATSONS LABS/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x -10.9 15.5 - View Chart
P/BV x 0.2 1.8 9.0% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 DR. DATSONS LABS   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
JUBILANT LIFE SCIENCES
Mar-19
DR. DATSONS LABS/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs126898 14.0%   
Low Rs31618 5.0%   
Sales per share (Unadj.) Rs133.0572.0 23.3%  
Earnings per share (Unadj.) Rs0.236.2 0.4%  
Cash flow per share (Unadj.) Rs6.659.5 11.1%  
Dividends per share (Unadj.) Rs04.50 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs128.8301.9 42.7%  
Shares outstanding (eoy) m31.66159.28 19.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.3 44.4%   
Avg P/E ratio x516.120.9 2,467.5%  
P/CF ratio (eoy) x11.812.7 93.0%  
Price / Book Value ratio x0.62.5 24.2%  
Dividend payout %012.4 0.0%   
Avg Mkt Cap Rs m2,477120,694 2.1%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m5619,260 0.3%   
Avg. sales/employee Rs ThNM38,120.6-  
Avg. wages/employee Rs ThNM8,058.4-  
Avg. net profit/employee Rs ThNM2,414.3-  
INCOME DATA
Net Sales Rs m4,21191,108 4.6%  
Other income Rs m79357 22.0%   
Total revenues Rs m4,28991,466 4.7%   
Gross profit Rs m56917,390 3.3%  
Depreciation Rs m2043,709 5.5%   
Interest Rs m4302,198 19.6%   
Profit before tax Rs m1311,840 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m63,268 0.2%   
Profit after tax Rs m55,770 0.1%  
Gross profit margin %13.519.1 70.8%  
Effective tax rate %48.027.6 174.0%   
Net profit margin %0.16.3 1.8%  
BALANCE SHEET DATA
Current assets Rs m6,85245,848 14.9%   
Current liabilities Rs m6,71120,897 32.1%   
Net working cap to sales %3.327.4 12.2%  
Current ratio x1.02.2 46.5%  
Inventory Days Days16157 283.2%  
Debtors Days Days31851 625.2%  
Net fixed assets Rs m3,67365,498 5.6%   
Share capital Rs m317159 198.7%   
"Free" reserves Rs m3,76147,930 7.8%   
Net worth Rs m4,07848,089 8.5%   
Long term debt Rs m1,67142,429 3.9%   
Total assets Rs m12,633114,685 11.0%  
Interest coverage x1.06.4 16.1%   
Debt to equity ratio x0.40.9 46.4%  
Sales to assets ratio x0.30.8 42.0%   
Return on assets %3.46.9 49.6%  
Return on equity %0.112.0 1.0%  
Return on capital %7.712.4 61.8%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96412,422 7.8%   
Fx outflow Rs m60717,227 3.5%   
Net fx Rs m357-4,805 -7.4%   
CASH FLOW
From Operations Rs m1,34511,215 12.0%  
From Investments Rs m-2,256-10,118 22.3%  
From Financial Activity Rs m-1,2006,574 -18.2%  
Net Cashflow Rs m-2,1117,612 -27.7%  

Share Holding

Indian Promoters % 4.5 45.6 9.9%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 0.0 8.7 -  
FIIs % 1.4 21.2 6.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 21.1 446.0%  
Shareholders   20,807 23,815 87.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GLENMARK PHARMA  FULFORD INDIA  PROCTER & GAMBLE HEALTH  DIVIS LABORATORIES  UNICHEM LAB  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS